|
|
|
|
Dr. Rachel Sherman, a former Principal Deputy Commissioner of the FDA, explains expert regulatory guidance by transforming complex issues into clear, actionable strategies. With decades of experience in science and law, she helps biopharma leaders navigate clinical program challenges, anticipating and resolving problems when stakes are highest.
|
|
|
|
|
Why is the idea of being “rescued” celebrated in some situations, but met with resistance in others? The willingness to seek support from Rescue CROs when clinical trials face challenges is not a sign of weakness, but a demonstration of accountability and commitment to excellence.
|
|
|
|
|
Explore the fascinating intersection of AI, software, and biology as Yochi Slonim, cofounder and CEO of Anima Biotech, shares his unconventional and breakthrough journey from debugging software to decoding disease and accelerating impactful drug discovery at the cellular level.
|
|
|
|
|
In this continued conversation, AI is shifting from generating accessible ideas to powering disease models built on proprietary biological data. This evolution hinges on smarter large language models, reduced hallucinations, and the strategic use of missing information to unlock new possibilities in drug discovery.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
When Clinical Trials Drift Off Course
|
Recovering lost clinical trials is an art. Learn how we triage your study’s problem areas, build tailored recovery strategies to address your drifting trial’s performance, and consistently deliver measurable, meaningful results.
|
|
• Request Information
|
|
|
|
|
|
|
|
